standards > model/format > DOI:10.25504/FAIRsharing.qw67v6
Did we miss something? Our COVID-19 Collection is growing, but not yet complete. Tell us what's missing. Email or add missing resources to our spreadsheet

uncertain Adverse Drug Reaction Markup Language

Abbreviation: EU-ADR ML

General Information
The Adverse Drug Reaction Markup Language (EU-ADR ML) was created to as part of the EU-ADR project. The ultimate aim of this project was to develop an innovative approach to the early detection of adverse drug reactions. The status of this format is uncertain as FAIRsharing cannot find documentation for the format itself beyond what is available in this record.

How to cite this record EU-ADR ML; Adverse Drug Reaction Markup Language; DOI:; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Sep 19 2020 7:37 p.m.

Record updated: March 15, 2018, 10:38 a.m. by The FAIRsharing Team.

Show edit history



    No tools defined


Access / Retrieve Data

Conditions of Use


The EU-ADR project: preliminary results and perspective.

Trifiro G,Fourrier-Reglat A,Sturkenboom MC,Diaz Acedo C,Van Der Lei J
Stud Health Technol Inform 2009

View Paper (PubMed) View Publication

Related Standards

Reporting Guidelines

No guidelines defined

Terminology Artifacts

No semantic standards defined

Models and Formats

Identifier Schemas

No identifier schema standards defined


No metrics standards defined

Related Databases (0)

No Related Databases

Implementing Policies

This record is not implemented by any policy.


Record Maintainer

  • This record is in need of a maintainer. If you login, you'll be able to claim this record.